Oxcarbazepine
NDC 50742-613, Oxcarbazepine, tablet, extended release, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-613
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215796
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE600 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-613-01 | 50742061301 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-613-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/70798ca9-0eda-49c0-8a7c-b775b6ae3d69NADAC price for package 50742061301
GET /v1/drugs/nadac/50742061301
Use it
Look up 50742-613 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.